Navigation Links
Organovo Partners With ZenBio to Create 3D Tissue Models
Date:2/20/2013

SAN DIEGO, Feb. 20, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, and ZenBio Inc., a leading provider of advanced cell-based solutions and services, are partnering to produce three-dimensional human tissues for drug discovery and advanced tissue therapies.

ZenBio will provide unique, validated cellular inputs for use by Organovo with its NovoGen™ bioprinting technology to enable the generation of living, three-dimensional tissues that reproduce the architectural and functional features of tissues inside the human body. The resulting 3D tissue models may lead to advances in medical research, drug discovery and development as well as direct therapies and transplantation.

"ZenBio is a highly respected provider of human cells, which are key inputs to our 3D tissue models," said Keith Murphy , Chairman and Chief Executive Officer at Organovo. "Together, we can create new tissues and disease models that offer greater preclinical predictive value for drug discovery, and will fill unmet needs for medical research and surgical therapies."

"At ZenBio, we recognize the shift towards 3D cell culturing platforms for assay development. This is especially true for potency assays, which are a regulatory requirement for tissue engineered and regenerative medicine therapeutics.  Additionally, our commercial and academic clients are continually seeking 3D cell culturing products as a bridge towards in vivo studies. Organovo's  technology has the ability to satisfy the regulatory, academic, and commercial needs for 3D cell culturing," said Dr. John W. Ludlow , Executive Director of Regenerative Medicine at ZenBio Inc.

About Organovo Holdings, Inc.
Organovo designs and creates functional,
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
2. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
3. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
4. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
5. Organovo Announces Relocation and Commencement of Operations at Larger Facility
6. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
7. Organovo To Present At Lazard Healthcare Conference
8. Organovo Reports Q3 2012 Financial Results, Provides Business Update
9. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
11. Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of XMRI.com, New System by USARAD.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... (PRWEB) November 23, 2014 One of the ... of optics and photonics is now available to high school ... low cost. SPIE, the international society for optics and ... the complete SPIE Digital Library available to high ... , “Light-based technologies are integral to all areas of life ...
(Date:11/24/2014)... Nov. 24, 2014  Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  Spherix v. ... both in the United States District Court for ... . On November 21, 2014 ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 During his ... understood the need to surround himself with great people ... and entrepreneur, his friends often marveled at his extraordinarily ... lived his life and -- even with his death ... the Alzheimer’s disease that would ultimately take his life. ...
(Date:11/22/2014)... On November 17th Chicago start-up Briteseed outperformed ... Technologies Summit in San Francisco to take first place ... Silicon Valley investors and technology elites as the premier ... positions Briteseed to move on to the final ... compete with other elite innovation finalists for a $125,000 ...
Breaking Biology Technology:SPIE Digital Library Now Available to High Schools, Two-Year Colleges at No or Low Cost 2Markman Hearing Held as Scheduled in VTech and Uniden Cases 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3
... Research & Development Team, CLINTON, N.J., ... fully,integrated critical care biotherapeutics company, announced that ... President of Translational,Medicine, reporting to Ralf Rosskamp, ... of Ikaria., As Vice President of ...
... Thursday, June 26th at 2:30pm ET, NEW YORK, ... today announced that Michael S. Weiss, the Company,s,Chairman and ... & Co. Healthcare Conference being held in New York ... on Thursday, June 26th at,2:30pm ET and will be ...
... New Generation Biofuels,Holdings, Inc. (AMEX: GNB ), a ... Exchange (AMEX) in mid-April, will join the Russell,Microcap Index ... Friday, June 27th, after the market closes, according to ... ., Membership in the Russell Microcap Index, which ...
Cached Biology Technology:Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine 2Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine 3Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference 2New Generation Biofuels Set to Join Russell Microcap Index 2New Generation Biofuels Set to Join Russell Microcap Index 3
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
(Date:11/2/2014)... issue of Physics World , James Dacey explores ... of death" to take their innovations from the lab ... gruelling challenge facing all start-up companies as they move ... because of two main factors: physics-based inventions are usually ... turn out to be a lot more complicated than ...
(Date:11/2/2014)... put a flashlight up to our palms to see ... St. Louis engineers are using a similar idea to ... of cancerous tissues and to develop potential treatments. ... Professor of Biomedical Engineering at the School of Engineering ... that allows researchers to better focus light in tissue, ...
Breaking Biology News(10 mins):NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3The 'valley of death' facing physics start-ups 2Improving imaging of cancerous tissues by reversing time 2
... 2008) Argonne National Laboratory has signed a ... Laboratory (SRNL) to collaborate on nuclear energy and ... U.S. Energy Department (DOE) needs and other important ... remain a leader in nuclear energy research," Argonne ...
... the molecule hydroxyl on another planet for the first ... to unlock the workings of Venuss dense atmosphere. ... of a hydrogen and oxygen atom each. It has ... atmosphere, some 100 km above the surface, by Venus ...
... tea may be able to stave off the cognitive ... to a new study published in the second issue ... of Respiratory and Critical Care Medicine. Researchers examined ... water, on rats who were intermittently deprived of oxygen ...
Cached Biology News:Argonne-SRNL agreement supports critical DOE, national priorities 2Key molecule discovered in Venus's atmosphere 2Green tea compounds beat OSA-related brain deficits 2
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Mouse polyclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = 25797...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: